A technology developed at OHSU’s Casey Eye Institute that uses artificial intelligence to better identify the blinding disease retinopathy of prematurity than most human experts.
OHSU Casey Eye Institute clinicians recently performed the first CRISPR gene editing procedure within the human body as part of a clinical trial to address a blindness-causing gene mutation.
An article features the “incredible” outcome experienced by a Grants Pass resident who underwent deep brain stimulation at OHSU to treat essential tremor.
A column authored by Joel Nigg, Ph.D., notes ADHD is not a “one-size-fits-all” condition and affects children in different ways. According to Nigg, each patient and family should work with health care providers to develop a personalized treatment plan.